GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0000902 | Cell morphogenesis |
| Process | GO:0001501 | Skeletal system development |
| Process | GO:0001505 | Regulation of neurotransmitter levels |
| Process | GO:0001508 | Action potential |
| Process | GO:0001775 | Cell activation |
| Process | GO:0001776 | Leukocyte homeostasis |
| Process | GO:0001817 | Regulation of cytokine production |
| Process | GO:0001819 | Positive regulation of cytokine production |
| Process | GO:0001845 | Phagolysosome assembly |
| Process | GO:0001894 | Tissue homeostasis |
| Process | GO:0001910 | Regulation of leukocyte mediated cytotoxicity |
| Process | GO:0001912 | Positive regulation of leukocyte mediated cytotoxicity |
| Process | GO:0001914 | Regulation of T cell mediated cytotoxicity |
| Process | GO:0001916 | Positive regulation of T cell mediated cytotoxicity |
| Process | GO:0001932 | Regulation of protein phosphorylation |
| Process | GO:0001934 | Positive regulation of protein phosphorylation |
| Process | GO:0002028 | Regulation of sodium ion transport |
| Process | GO:0002237 | Response to molecule of bacterial origin |
| Process | GO:0002260 | Lymphocyte homeostasis |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002682 | Regulation of immune system process |
| Process | GO:0002684 | Positive regulation of immune system process |
| Process | GO:0002697 | Regulation of immune effector process |
| Process | GO:0002699 | Positive regulation of immune effector process |
| Process | GO:0002703 | Regulation of leukocyte mediated immunity |
| Process | GO:0002705 | Positive regulation of leukocyte mediated immunity |
| Process | GO:0002706 | Regulation of lymphocyte mediated immunity |
| Process | GO:0002708 | Positive regulation of lymphocyte mediated immunity |
| Process | GO:0002709 | Regulation of T cell mediated immunity |
| Process | GO:0002711 | Positive regulation of T cell mediated immunity |
| Process | GO:0002819 | Regulation of adaptive immune response |
| Process | GO:0002821 | Positive regulation of adaptive immune response |
| Process | GO:0002822 | Regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| Process | GO:0002824 | Positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| Process | GO:0003008 | System process |
| Process | GO:0003254 | Regulation of membrane depolarization |
| Process | GO:0006109 | Regulation of carbohydrate metabolic process |
| Process | GO:0006110 | Regulation of glycolytic process |
| Process | GO:0006140 | Regulation of nucleotide metabolic process |
| Process | GO:0006468 | Protein phosphorylation |
| Process | GO:0006508 | Proteolysis |
| Process | GO:0006509 | Membrane protein ectodomain proteolysis |
| Process | GO:0006629 | Lipid metabolic process |
| Process | GO:0006643 | Membrane lipid metabolic process |
| Process | GO:0006649 | Phospholipid transfer to membrane |
| Process | GO:0006665 | Sphingolipid metabolic process |
| Process | GO:0006672 | Ceramide metabolic process |
| Process | GO:0006793 | Phosphorus metabolic process |
| Process | GO:0006796 | Phosphate-containing compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006810 | Transport |
| Process | GO:0006811 | Ion transport |
| Process | GO:0006812 | Cation transport |
| Process | GO:0006816 | Calcium ion transport |
| Process | GO:0006820 | Anion transport |
| Process | GO:0006836 | Neurotransmitter transport |
| Process | GO:0006862 | Nucleotide transport |
| Process | GO:0006869 | Lipid transport |
| Process | GO:0006884 | Cell volume homeostasis |
| Process | GO:0006887 | Exocytosis |
| Process | GO:0006900 | Vesicle budding from membrane |
| Process | GO:0006909 | Phagocytosis |
| Process | GO:0006915 | Apoptotic process |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006952 | Defense response |
| Process | GO:0006954 | Inflammatory response |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007005 | Mitochondrion organization |
| Process | GO:0007009 | Plasma membrane organization |
| Process | GO:0007033 | Vacuole organization |
| Process | GO:0007040 | Lysosome organization |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007166 | Cell surface receptor signaling pathway |
| Process | GO:0007204 | Positive regulation of cytosolic calcium ion concentration |
| Process | GO:0007267 | Cell-cell signaling |
| Process | GO:0007268 | Chemical synaptic transmission |
| Process | GO:0007269 | Neurotransmitter secretion |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007600 | Sensory perception |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008219 | Cell death |
| Process | GO:0008283 | Cell population proliferation |
| Process | GO:0008361 | Regulation of cell size |
| Process | GO:0008610 | Lipid biosynthetic process |
| Process | GO:0009056 | Catabolic process |
| Process | GO:0009057 | Macromolecule catabolic process |
| Process | GO:0009058 | Biosynthetic process |
| Process | GO:0009410 | Response to xenobiotic stimulus |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009612 | Response to mechanical stimulus |
| Process | GO:0009617 | Response to bacterium |
| Process | GO:0009628 | Response to abiotic stimulus |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009887 | Animal organ morphogenesis |
| Process | GO:0009893 | Positive regulation of metabolic process |
| Process | GO:0009894 | Regulation of catabolic process |
| Process | GO:0009896 | Positive regulation of catabolic process |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009967 | Positive regulation of signal transduction |
| Process | GO:0009968 | Negative regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0009991 | Response to extracellular stimulus |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010035 | Response to inorganic substance |
| Process | GO:0010038 | Response to metal ion |
| Process | GO:0010043 | Response to zinc ion |
| Process | GO:0010243 | Response to organonitrogen compound |
| Process | GO:0010256 | Endomembrane system organization |
| Process | GO:0010467 | Gene expression |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010522 | Regulation of calcium ion transport into cytosol |
| Process | GO:0010524 | Positive regulation of calcium ion transport into cytosol |
| Process | GO:0010562 | Positive regulation of phosphorus metabolic process |
| Process | GO:0010604 | Positive regulation of macromolecule metabolic process |
| Process | GO:0010628 | Positive regulation of gene expression |
| Process | GO:0010638 | Positive regulation of organelle organization |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010647 | Positive regulation of cell communication |
| Process | GO:0010648 | Negative regulation of cell communication |
| Process | GO:0010876 | Lipid localization |
| Process | GO:0010941 | Regulation of cell death |
| Process | GO:0010942 | Positive regulation of cell death |
| Process | GO:0010959 | Regulation of metal ion transport |
| Process | GO:0012501 | Programmed cell death |
| Process | GO:0014048 | Regulation of glutamate secretion |
| Process | GO:0014049 | Positive regulation of glutamate secretion |
| Process | GO:0014052 | Regulation of gamma-aminobutyric acid secretion |
| Process | GO:0014054 | Positive regulation of gamma-aminobutyric acid secretion |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0014074 | Response to purine-containing compound |
| Process | GO:0015695 | Organic cation transport |
| Process | GO:0015711 | Organic anion transport |
| Process | GO:0015748 | Organophosphate ester transport |
| Process | GO:0015865 | Purine nucleotide transport |
| Process | GO:0015867 | ATP transport |
| Process | GO:0015868 | Purine ribonucleotide transport |
| Process | GO:0015914 | Phospholipid transport |
| Process | GO:0015931 | Nucleobase-containing compound transport |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016050 | Vesicle organization |
| Process | GO:0016079 | Synaptic vesicle exocytosis |
| Process | GO:0016192 | Vesicle-mediated transport |
| Process | GO:0016310 | Phosphorylation |
| Process | GO:0016485 | Protein processing |
| Process | GO:0017121 | Plasma membrane phospholipid scrambling |
| Process | GO:0017157 | Regulation of exocytosis |
| Process | GO:0017158 | Regulation of calcium ion-dependent exocytosis |
| Process | GO:0019219 | Regulation of nucleobase-containing compound metabolic process |
| Process | GO:0019220 | Regulation of phosphate metabolic process |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019226 | Transmission of nerve impulse |
| Process | GO:0019228 | Neuronal action potential |
| Process | GO:0019233 | Sensory perception of pain |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0019725 | Cellular homeostasis |
| Process | GO:0022607 | Cellular component assembly |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023052 | Signaling |
| Process | GO:0023056 | Positive regulation of signaling |
| Process | GO:0023057 | Negative regulation of signaling |
| Process | GO:0023061 | Signal release |
| Process | GO:0030001 | Metal ion transport |
| Process | GO:0030030 | Cell projection organization |
| Process | GO:0030031 | Cell projection assembly |
| Process | GO:0030148 | Sphingolipid biosynthetic process |
| Process | GO:0030163 | Protein catabolic process |
| Process | GO:0030278 | Regulation of ossification |
| Process | GO:0030500 | Regulation of bone mineralization |
| Process | GO:0030501 | Positive regulation of bone mineralization |
| Process | GO:0031323 | Regulation of cellular metabolic process |
| Process | GO:0031325 | Positive regulation of cellular metabolic process |
| Process | GO:0031329 | Regulation of cellular catabolic process |
| Process | GO:0031331 | Positive regulation of cellular catabolic process |
| Process | GO:0031341 | Regulation of cell killing |
| Process | GO:0031343 | Positive regulation of cell killing |
| Process | GO:0031344 | Regulation of cell projection organization |
| Process | GO:0031346 | Positive regulation of cell projection organization |
| Process | GO:0031399 | Regulation of protein modification process |
| Process | GO:0031401 | Positive regulation of protein modification process |
| Process | GO:0031668 | Cellular response to extracellular stimulus |
| Process | GO:0032060 | Bleb assembly |
| Process | GO:0032147 | Activation of protein kinase activity |
| Process | GO:0032303 | Regulation of icosanoid secretion |
| Process | GO:0032305 | Positive regulation of icosanoid secretion |
| Process | GO:0032306 | Regulation of prostaglandin secretion |
| Process | GO:0032308 | Positive regulation of prostaglandin secretion |
| Process | GO:0032368 | Regulation of lipid transport |
| Process | GO:0032370 | Positive regulation of lipid transport |
| Process | GO:0032496 | Response to lipopolysaccharide |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032535 | Regulation of cellular component size |
| Process | GO:0032650 | Regulation of interleukin-1 alpha production |
| Process | GO:0032651 | Regulation of interleukin-1 beta production |
| Process | GO:0032652 | Regulation of interleukin-1 production |
| Process | GO:0032675 | Regulation of interleukin-6 production |
| Process | GO:0032730 | Positive regulation of interleukin-1 alpha production |
| Process | GO:0032731 | Positive regulation of interleukin-1 beta production |
| Process | GO:0032732 | Positive regulation of interleukin-1 production |
| Process | GO:0032755 | Positive regulation of interleukin-6 production |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032880 | Regulation of protein localization |
| Process | GO:0032890 | Regulation of organic acid transport |
| Process | GO:0032892 | Positive regulation of organic acid transport |
| Process | GO:0032940 | Secretion by cell |
| Process | GO:0032943 | Mononuclear cell proliferation |
| Process | GO:0032963 | Collagen metabolic process |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033043 | Regulation of organelle organization |
| Process | GO:0033198 | Response to ATP |
| Process | GO:0033619 | Membrane protein proteolysis |
| Process | GO:0033674 | Positive regulation of kinase activity |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0034103 | Regulation of tissue remodeling |
| Process | GO:0034104 | Negative regulation of tissue remodeling |
| Process | GO:0034204 | Lipid translocation |
| Process | GO:0034220 | Ion transmembrane transport |
| Process | GO:0034405 | Response to fluid shear stress |
| Process | GO:0034641 | Cellular nitrogen compound metabolic process |
| Process | GO:0034762 | Regulation of transmembrane transport |
| Process | GO:0034764 | Positive regulation of transmembrane transport |
| Process | GO:0034765 | Regulation of ion transmembrane transport |
| Process | GO:0034767 | Positive regulation of ion transmembrane transport |
| Process | GO:0035590 | Purinergic nucleotide receptor signaling pathway |
| Process | GO:0035637 | Multicellular organismal signaling |
| Process | GO:0036211 | Protein modification process |
| Process | GO:0042098 | T cell proliferation |
| Process | GO:0042110 | T cell activation |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042325 | Regulation of phosphorylation |
| Process | GO:0042327 | Positive regulation of phosphorylation |
| Process | GO:0042391 | Regulation of membrane potential |
| Process | GO:0042592 | Homeostatic process |
| Process | GO:0042742 | Defense response to bacterium |
| Process | GO:0042981 | Regulation of apoptotic process |
| Process | GO:0043029 | T cell homeostasis |
| Process | GO:0043065 | Positive regulation of apoptotic process |
| Process | GO:0043067 | Regulation of programmed cell death |
| Process | GO:0043068 | Positive regulation of programmed cell death |
| Process | GO:0043085 | Positive regulation of catalytic activity |
| Process | GO:0043132 | NAD transport |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0043269 | Regulation of ion transport |
| Process | GO:0043270 | Positive regulation of ion transport |
| Process | GO:0043331 | Response to dsRNA |
| Process | GO:0043405 | Regulation of MAP kinase activity |
| Process | GO:0043406 | Positive regulation of MAP kinase activity |
| Process | GO:0043408 | Regulation of MAPK cascade |
| Process | GO:0043409 | Negative regulation of MAPK cascade |
| Process | GO:0043410 | Positive regulation of MAPK cascade |
| Process | GO:0043412 | Macromolecule modification |
| Process | GO:0043467 | Regulation of generation of precursor metabolites and energy |
| Process | GO:0043470 | Regulation of carbohydrate catabolic process |
| Process | GO:0043549 | Regulation of kinase activity |
| Process | GO:0043603 | Cellular amide metabolic process |
| Process | GO:0043604 | Amide biosynthetic process |
| Process | GO:0043933 | Protein-containing complex organization |
| Process | GO:0044070 | Regulation of anion transport |
| Process | GO:0044085 | Cellular component biogenesis |
| Process | GO:0044087 | Regulation of cellular component biogenesis |
| Process | GO:0044089 | Positive regulation of cellular component biogenesis |
| Process | GO:0044093 | Positive regulation of molecular function |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044249 | Cellular biosynthetic process |
| Process | GO:0044255 | Cellular lipid metabolic process |
| Process | GO:0044271 | Cellular nitrogen compound biosynthetic process |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0045055 | Regulated exocytosis |
| Process | GO:0045124 | Regulation of bone resorption |
| Process | GO:0045321 | Leukocyte activation |
| Process | GO:0045332 | Phospholipid translocation |
| Process | GO:0045778 | Positive regulation of ossification |
| Process | GO:0045779 | Negative regulation of bone resorption |
| Process | GO:0045794 | Negative regulation of cell volume |
| Process | GO:0045821 | Positive regulation of glycolytic process |
| Process | GO:0045859 | Regulation of protein kinase activity |
| Process | GO:0045860 | Positive regulation of protein kinase activity |
| Process | GO:0045913 | Positive regulation of carbohydrate metabolic process |
| Process | GO:0045935 | Positive regulation of nucleobase-containing compound metabolic process |
| Process | GO:0045937 | Positive regulation of phosphate metabolic process |
| Process | GO:0045981 | Positive regulation of nucleotide metabolic process |
| Process | GO:0046467 | Membrane lipid biosynthetic process |
| Process | GO:0046513 | Ceramide biosynthetic process |
| Process | GO:0046649 | Lymphocyte activation |
| Process | GO:0046651 | Lymphocyte proliferation |
| Process | GO:0046683 | Response to organophosphorus |
| Process | GO:0046850 | Regulation of bone remodeling |
| Process | GO:0046851 | Negative regulation of bone remodeling |
| Process | GO:0046903 | Secretion |
| Process | GO:0046928 | Regulation of neurotransmitter secretion |
| Process | GO:0046931 | Pore complex assembly |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048584 | Positive regulation of response to stimulus |
| Process | GO:0048585 | Negative regulation of response to stimulus |
| Process | GO:0048705 | Skeletal system morphogenesis |
| Process | GO:0048731 | System development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048871 | Multicellular organismal homeostasis |
| Process | GO:0048872 | Homeostasis of number of cells |
| Process | GO:0048873 | Homeostasis of number of cells within a tissue |
| Process | GO:0050708 | Regulation of protein secretion |
| Process | GO:0050714 | Positive regulation of protein secretion |
| Process | GO:0050776 | Regulation of immune response |
| Process | GO:0050778 | Positive regulation of immune response |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050804 | Modulation of chemical synaptic transmission |
| Process | GO:0050830 | Defense response to Gram-positive bacterium |
| Process | GO:0050877 | Nervous system process |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051046 | Regulation of secretion |
| Process | GO:0051047 | Positive regulation of secretion |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051050 | Positive regulation of transport |
| Process | GO:0051094 | Positive regulation of developmental process |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051130 | Positive regulation of cellular component organization |
| Process | GO:0051171 | Regulation of nitrogen compound metabolic process |
| Process | GO:0051173 | Positive regulation of nitrogen compound metabolic process |
| Process | GO:0051174 | Regulation of phosphorus metabolic process |
| Process | GO:0051179 | Localization |
| Process | GO:0051209 | Release of sequestered calcium ion into cytosol |
| Process | GO:0051222 | Positive regulation of protein transport |
| Process | GO:0051223 | Regulation of protein transport |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051240 | Positive regulation of multicellular organismal process |
| Process | GO:0051241 | Negative regulation of multicellular organismal process |
| Process | GO:0051246 | Regulation of protein metabolic process |
| Process | GO:0051247 | Positive regulation of protein metabolic process |
| Process | GO:0051282 | Regulation of sequestering of calcium ion |
| Process | GO:0051283 | Negative regulation of sequestering of calcium ion |
| Process | GO:0051338 | Regulation of transferase activity |
| Process | GO:0051347 | Positive regulation of transferase activity |
| Process | GO:0051493 | Regulation of cytoskeleton organization |
| Process | GO:0051495 | Positive regulation of cytoskeleton organization |
| Process | GO:0051503 | Adenine nucleotide transport |
| Process | GO:0051588 | Regulation of neurotransmitter transport |
| Process | GO:0051592 | Response to calcium ion |
| Process | GO:0051602 | Response to electrical stimulus |
| Process | GO:0051604 | Protein maturation |
| Process | GO:0051641 | Cellular localization |
| Process | GO:0051649 | Establishment of localization in cell |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051881 | Regulation of mitochondrial membrane potential |
| Process | GO:0051899 | Membrane depolarization |
| Process | GO:0051900 | Regulation of mitochondrial depolarization |
| Process | GO:0051901 | Positive regulation of mitochondrial depolarization |
| Process | GO:0051924 | Regulation of calcium ion transport |
| Process | GO:0051928 | Positive regulation of calcium ion transport |
| Process | GO:0051952 | Regulation of amine transport |
| Process | GO:0051954 | Positive regulation of amine transport |
| Process | GO:0051955 | Regulation of amino acid transport |
| Process | GO:0051957 | Positive regulation of amino acid transport |
| Process | GO:0055085 | Transmembrane transport |
| Process | GO:0060078 | Regulation of postsynaptic membrane potential |
| Process | GO:0060079 | Excitatory postsynaptic potential |
| Process | GO:0060249 | Anatomical structure homeostasis |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060341 | Regulation of cellular localization |
| Process | GO:0060491 | Regulation of cell projection assembly |
| Process | GO:0060627 | Regulation of vesicle-mediated transport |
| Process | GO:0061024 | Membrane organization |
| Process | GO:0062012 | Regulation of small molecule metabolic process |
| Process | GO:0062013 | Positive regulation of small molecule metabolic process |
| Process | GO:0065003 | Protein-containing complex assembly |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070167 | Regulation of biomineral tissue development |
| Process | GO:0070169 | Positive regulation of biomineral tissue development |
| Process | GO:0070201 | Regulation of establishment of protein localization |
| Process | GO:0070228 | Regulation of lymphocyte apoptotic process |
| Process | GO:0070230 | Positive regulation of lymphocyte apoptotic process |
| Process | GO:0070588 | Calcium ion transmembrane transport |
| Process | GO:0070661 | Leukocyte proliferation |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0070925 | Organelle assembly |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071359 | Cellular response to dsRNA |
| Process | GO:0071407 | Cellular response to organic cyclic compound |
| Process | GO:0071496 | Cellular response to external stimulus |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0071900 | Regulation of protein serine/threonine kinase activity |
| Process | GO:0071902 | Positive regulation of protein serine/threonine kinase activity |
| Process | GO:0072593 | Reactive oxygen species metabolic process |
| Process | GO:0080090 | Regulation of primary metabolic process |
| Process | GO:0080171 | Lytic vacuole organization |
| Process | GO:0090066 | Regulation of anatomical structure size |
| Process | GO:0090382 | Phagosome maturation |
| Process | GO:0097035 | Regulation of membrane lipid distribution |
| Process | GO:0097190 | Apoptotic signaling pathway |
| Process | GO:0097191 | Extrinsic apoptotic signaling pathway |
| Process | GO:0097553 | Calcium ion transmembrane import into cytosol |
| Process | GO:0098542 | Defense response to other organism |
| Process | GO:0098655 | Cation transmembrane transport |
| Process | GO:0098660 | Inorganic ion transmembrane transport |
| Process | GO:0098662 | Inorganic cation transmembrane transport |
| Process | GO:0098916 | Anterograde trans-synaptic signaling |
| Process | GO:0099003 | Vesicle-mediated transport in synapse |
| Process | GO:0099161 | Regulation of presynaptic dense core granule exocytosis |
| Process | GO:0099171 | Presynaptic modulation of chemical synaptic transmission |
| Process | GO:0099177 | Regulation of trans-synaptic signaling |
| Process | GO:0099504 | Synaptic vesicle cycle |
| Process | GO:0099536 | Synaptic signaling |
| Process | GO:0099537 | Trans-synaptic signaling |
| Process | GO:0099565 | Chemical synaptic transmission, postsynaptic |
| Process | GO:0099643 | Signal release from synapse |
| Process | GO:0110149 | Regulation of biomineralization |
| Process | GO:0110151 | Positive regulation of biomineralization |
| Process | GO:0120031 | Plasma membrane bounded cell projection assembly |
| Process | GO:0120032 | Regulation of plasma membrane bounded cell projection assembly |
| Process | GO:0120034 | Positive regulation of plasma membrane bounded cell projection assembly |
| Process | GO:0120035 | Regulation of plasma membrane bounded cell projection organization |
| Process | GO:0120036 | Plasma membrane bounded cell projection organization |
| Process | GO:0140352 | Export from cell |
| Process | GO:1900542 | Regulation of purine nucleotide metabolic process |
| Process | GO:1900544 | Positive regulation of purine nucleotide metabolic process |
| Process | GO:1901264 | Carbohydrate derivative transport |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901565 | Organonitrogen compound catabolic process |
| Process | GO:1901566 | Organonitrogen compound biosynthetic process |
| Process | GO:1901575 | Organic substance catabolic process |
| Process | GO:1901576 | Organic substance biosynthetic process |
| Process | GO:1901698 | Response to nitrogen compound |
| Process | GO:1901699 | Cellular response to nitrogen compound |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1902531 | Regulation of intracellular signal transduction |
| Process | GO:1902532 | Negative regulation of intracellular signal transduction |
| Process | GO:1902533 | Positive regulation of intracellular signal transduction |
| Process | GO:1903169 | Regulation of calcium ion transmembrane transport |
| Process | GO:1903233 | Regulation of calcium ion-dependent exocytosis of neurotransmitter |
| Process | GO:1903305 | Regulation of regulated secretory pathway |
| Process | GO:1903530 | Regulation of secretion by cell |
| Process | GO:1903532 | Positive regulation of secretion by cell |
| Process | GO:1903578 | Regulation of ATP metabolic process |
| Process | GO:1903580 | Positive regulation of ATP metabolic process |
| Process | GO:1903793 | Positive regulation of anion transport |
| Process | GO:1903829 | Positive regulation of protein localization |
| Process | GO:1904062 | Regulation of cation transmembrane transport |
| Process | GO:1904064 | Positive regulation of cation transmembrane transport |
| Process | GO:1904170 | Regulation of bleb assembly |
| Process | GO:1904172 | Positive regulation of bleb assembly |
| Process | GO:1904181 | Positive regulation of membrane depolarization |
| Process | GO:1904427 | Positive regulation of calcium ion transmembrane transport |
| Process | GO:1904669 | ATP export |
| Process | GO:1904951 | Positive regulation of establishment of protein localization |
| Process | GO:1905114 | Cell surface receptor signaling pathway involved in cell-cell signaling |
| Process | GO:1905413 | Regulation of dense core granule exocytosis |
| Process | GO:1905952 | Regulation of lipid localization |
| Process | GO:1905954 | Positive regulation of lipid localization |
| Process | GO:2000026 | Regulation of multicellular organismal development |
| Process | GO:2000106 | Regulation of leukocyte apoptotic process |
| Process | GO:2000108 | Positive regulation of leukocyte apoptotic process |
| Process | GO:2000191 | Regulation of fatty acid transport |
| Process | GO:2000193 | Positive regulation of fatty acid transport |
| Process | GO:2000300 | Regulation of synaptic vesicle exocytosis |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005635 | Nuclear envelope |
| Component | GO:0005637 | Nuclear inner membrane |
| Component | GO:0005639 | Integral component of nuclear inner membrane |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005887 | Integral component of plasma membrane |
| Component | GO:0005911 | Cell-cell junction |
| Component | GO:0009897 | External side of plasma membrane |
| Component | GO:0009986 | Cell surface |
| Component | GO:0012505 | Endomembrane system |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0019866 | Organelle inner membrane |
| Component | GO:0030054 | Cell junction |
| Component | GO:0030424 | Axon |
| Component | GO:0031090 | Organelle membrane |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031226 | Intrinsic component of plasma membrane |
| Component | GO:0031229 | Intrinsic component of nuclear inner membrane |
| Component | GO:0031300 | Intrinsic component of organelle membrane |
| Component | GO:0031301 | Integral component of organelle membrane |
| Component | GO:0031594 | Neuromuscular junction |
| Component | GO:0031965 | Nuclear membrane |
| Component | GO:0031967 | Organelle envelope |
| Component | GO:0031975 | Envelope |
| Component | GO:0032059 | Bleb |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0036477 | Somatodendritic compartment |
| Component | GO:0042995 | Cell projection |
| Component | GO:0043005 | Neuron projection |
| Component | GO:0043025 | Neuronal cell body |
| Component | GO:0043195 | Terminal bouton |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043679 | Axon terminus |
| Component | GO:0044297 | Cell body |
| Component | GO:0044306 | Neuron projection terminus |
| Component | GO:0045121 | Membrane raft |
| Component | GO:0045202 | Synapse |
| Component | GO:0070161 | Anchoring junction |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0098552 | Side of membrane |
| Component | GO:0098793 | Presynapse |
| Component | GO:0098794 | Postsynapse |
| Component | GO:0098857 | Membrane microdomain |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
| Component | GO:0150034 | Distal axon |
| Function | GO:0000166 | Nucleotide binding |
| Function | GO:0000287 | Magnesium ion binding |
| Function | GO:0001530 | Lipopolysaccharide binding |
| Function | GO:0001614 | Purinergic nucleotide receptor activity |
| Function | GO:0004888 | Transmembrane signaling receptor activity |
| Function | GO:0004931 | Extracellularly ATP-gated cation channel activity |
| Function | GO:0005102 | Signaling receptor binding |
| Function | GO:0005215 | Transporter activity |
| Function | GO:0005216 | Ion channel activity |
| Function | GO:0005230 | Extracellular ligand-gated ion channel activity |
| Function | GO:0005231 | Excitatory extracellular ligand-gated ion channel activity |
| Function | GO:0005261 | Cation channel activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005507 | Copper ion binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0005524 | ATP binding |
| Function | GO:0008047 | Enzyme activator activity |
| Function | GO:0008270 | Zinc ion binding |
| Function | GO:0008289 | Lipid binding |
| Function | GO:0008324 | Cation transmembrane transporter activity |
| Function | GO:0015075 | Ion transmembrane transporter activity |
| Function | GO:0015267 | Channel activity |
| Function | GO:0015276 | Ligand-gated ion channel activity |
| Function | GO:0015318 | Inorganic molecular entity transmembrane transporter activity |
| Function | GO:0016502 | Nucleotide receptor activity |
| Function | GO:0017076 | Purine nucleotide binding |
| Function | GO:0019207 | Kinase regulator activity |
| Function | GO:0019209 | Kinase activator activity |
| Function | GO:0019887 | Protein kinase regulator activity |
| Function | GO:0022803 | Passive transmembrane transporter activity |
| Function | GO:0022834 | Ligand-gated channel activity |
| Function | GO:0022836 | Gated channel activity |
| Function | GO:0022857 | Transmembrane transporter activity |
| Function | GO:0022890 | Inorganic cation transmembrane transporter activity |
| Function | GO:0030234 | Enzyme regulator activity |
| Function | GO:0030295 | Protein kinase activator activity |
| Function | GO:0030554 | Adenyl nucleotide binding |
| Function | GO:0032553 | Ribonucleotide binding |
| Function | GO:0032555 | Purine ribonucleotide binding |
| Function | GO:0032559 | Adenyl ribonucleotide binding |
| Function | GO:0035381 | ATP-gated ion channel activity |
| Function | GO:0035639 | Purine ribonucleoside triphosphate binding |
| Function | GO:0036094 | Small molecule binding |
| Function | GO:0038023 | Signaling receptor activity |
| Function | GO:0042802 | Identical protein binding |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043168 | Anion binding |
| Function | GO:0043169 | Cation binding |
| Function | GO:0043539 | Protein serine/threonine kinase activator activity |
| Function | GO:0046872 | Metal ion binding |
| Function | GO:0046914 | Transition metal ion binding |
| Function | GO:0060089 | Molecular transducer activity |
| Function | GO:0097110 | Scaffold protein binding |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0097367 | Carbohydrate derivative binding |
| Function | GO:0098772 | Molecular function regulator activity |
| Function | GO:0099094 | Ligand-gated cation channel activity |
| Function | GO:1901265 | Nucleoside phosphate binding |
| Function | GO:1901363 | Heterocyclic compound binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-109582 | Hemostasis |
| RCTM | RNO-139853 | Elevation of cytosolic Ca2+ levels |
| RCTM | RNO-168249 | Innate Immune System |
| RCTM | RNO-168256 | Immune System |
| RCTM | RNO-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| RCTM | RNO-418346 | Platelet homeostasis |
| RCTM | RNO-418360 | Platelet calcium homeostasis |
| RCTM | RNO-622312 | Inflammasomes |
| RCTM | RNO-844456 | The NLRP3 inflammasome |
Expression profile of P2rx7 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 5.2869773 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 3.7431626 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 4.484206 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 4.3849125 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 4.4438996 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 4.665861 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 3.1791213 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 4.8851595 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 3.263873 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 4.144741 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 3.9316103 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 3.1905763 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 2.5796952 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 3.305512 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 3.042111 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 2.7810366 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 3.6126678 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 3.7389717 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 3.4789042 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 3.3011255 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 5.136368 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 4.6468887 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 3.418876 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 4.1993513 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.666332165 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.992036761 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.0542848795 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.222781833 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.9714989215 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.5878962405 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 518.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 411.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 611.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 275.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 704.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 720.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 759.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1687.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 260.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 360.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 350.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 480.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 254.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 332.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 316.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 353.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.220962500000001 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.2062035 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.473254 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 6.917508 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.0620265 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.386404000000001 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 9.796 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 9.139 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 10.254 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 6.992 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 6.897 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 4.236748458 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 5.460340279 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 4.055333347 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 39.0 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 17.4 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 6.2 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 27.3 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 18.5 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 24.7 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 8.3 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 14.4 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 10.2 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 35.5 | |
| GSM27494 | CTL_a (control, 1st replicate) | 34.1 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 22.1 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 22.5 | |
| GSM27497 | CTL_d (control, 4th replicate) | 39.3 | |
| GSM27498 | CTL_e (control, 5th replicate) | 22.5 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 19.3 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 24.3 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 7.1 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 3.6 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 4.8 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 66.9 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 23.8 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 5.1 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 60.6 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 179.4 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 13.7 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 31.9 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 11.7 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 7.7 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 46.6 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 123.1 |
| GSM30791 | baseline control 02 | male, 275-300g | 102.4 |
| GSM30792 | baseline control 03 | male, 275-300g | 105.0 |
| GSM30793 | baseline control 04 | male, 275-300g | 148.8 |
| GSM30794 | baseline control 05 | male, 275-300g | 86.7 |
| GSM30795 | baseline control 06 | male, 275-300g | 67.1 |
| GSM30796 | baseline control 07 | male, 275-300g | 97.5 |
| GSM30797 | baseline control 08 | male, 275-300g | 88.6 |
| GSM30798 | baseline control 09 | male, 275-300g | 95.8 |
| GSM30799 | pain 01 | 167.9 | |
| GSM30800 | pain 02 | 122.7 | |
| GSM30801 | pain 03 | 230.6 | |
| GSM30802 | pain 04 | 107.6 | |
| GSM30803 | pain 05 | 125.4 | |
| GSM30804 | FC 01 | 217.3 | |
| GSM30805 | FC 02 | 76.1 | |
| GSM30806 | FC 03 | 103.6 | |
| GSM30807 | FC 04 | 109.0 | |
| GSM30808 | FC 05 | 102.3 | |
| GSM30809 | IFC 01 | 176.8 | |
| GSM30810 | IFC 02 | 105.7 | |
| GSM30811 | IFC 03 | 112.8 | |
| GSM30812 | IFC 04 | 60.8 | |
| GSM30813 | IFC 05 | 120.5 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 64.2 |
| GSM99801 | isoflurane 02 | male, 275-300g | 90.3 |
| GSM99802 | isoflurane 03 | male, 275-300g | 103.0 |
| GSM99803 | isoflurane 04 | male, 275-300g | 83.5 |
| GSM99804 | isoflurane 05 | male, 275-300g | 84.2 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 4.9826 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 5.1757 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 5.871 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 5.6464 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 6.5809 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 5.1167 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 6.0527 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 5.1123 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 5.5551 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 6.19135 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 6.34491 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 5.91223 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 5.81458 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 7.47964 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 7.20372 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 6.40254 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 6.44312 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 5.62608 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 6.10797 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 5.47645 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 6.01953 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 6.91284 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 6.40135 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 6.36562 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 5.39875 |
| ID | GSE21258 |
| Title | Transcript Profiling of Spinal Dorsal Horn in Response to Electroacupuncture on Rats at 1h |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM531353 | 2Hz_HR_1h_DH1 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531354 | 2Hz_HR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531355 | 2Hz_HR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531356 | 2Hz_HR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531357 | 2Hz_HR_1h_DH5 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531358 | 2Hz_LR_1h_DH1 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531359 | 2Hz_LR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531360 | 2Hz_LR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531361 | 2Hz_LR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 2Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531362 | 100Hz_HR_1h_DH1 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531363 | 100Hz_HR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531364 | 100Hz_HR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531365 | 100Hz_HR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531366 | 100Hz_HR_1h_DH5 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: high responder (HR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531367 | 100Hz_LR_1h_DH1 rat | time point: 1h;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats | 0.0 |
| GSM531368 | 100Hz_LR_1h_DH2 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531369 | 100Hz_LR_1h_DH3 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531370 | 100Hz_LR_1h_DH4 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| GSM531371 | 100Hz_LR_1h_DH5 rat | time point: 1h strain: Sprague-Dawley tissue type: spinal dorsal horn frequency: 100Hz group: low responder (LR) rats;strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation. | 0.0 |
| ID | GSE21733 |
| Title | Transcript Profiling of Spinal Dorsal Horn in Response to Electroacupuncture on Rats at 24h |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM542196 | 2Hz_HR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542197 | 2Hz_HR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.908935614 |
| GSM542198 | 2Hz_HR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -1.136914034 |
| GSM542199 | 2Hz_HR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH); strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 1.964062703 |
| GSM542200 | 2Hz_HR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.60644146 |
| GSM542201 | 2Hz_LR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.986747039 |
| GSM542202 | 2Hz_LR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 1.508159162 |
| GSM542203 | 2Hz_LR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542204 | 2Hz_LR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542205 | 2Hz_LR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 2Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542206 | 100Hz_HR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 1.182387305 |
| GSM542207 | 100Hz_HR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542208 | 100Hz_HR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542209 | 100Hz_HR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | -0.604457793 |
| GSM542210 | 100Hz_HR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: high responder (HR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.559707229 |
| GSM542211 | 100Hz_LR_24h_DH1 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542212 | 100Hz_LR_24h_DH2 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.129096114 |
| GSM542213 | 100Hz_LR_24h_DH3 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542214 | 100Hz_LR_24h_DH4 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| GSM542215 | 100Hz_LR_24h_DH5 rat | time point: 24h strain: Sprague-Dawley electroacupuncture frequency: 100Hz group: low responder (LR) rats tissue type: dorsal horn (DH);strain: Sprague-Dawley reference: rats sacrificed after stayed in their home cages without receiving electroacupuncture stimulation tissue type: dorsal horn (DH) | 0.0 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 30.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 22.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 49.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 39.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 35.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 30.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 52.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 31.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 30.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 42.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 30.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 34.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 33.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 33.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 62.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 42.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 34.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 26.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 29.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 39.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 36.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 47.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 55.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 40.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 31.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 42.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 35.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 31.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 39.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 31.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 49.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 47.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 36.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 38.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 50.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 42.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 19.178705 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 13.379595 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 20.797688 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 24.174213 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | -0.0914 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | 0.18 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | -0.199 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | 0.169 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | -0.00178 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | 0.073 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | 0.0837 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | -0.0758 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | 0.0116 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | 0.0356 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | 0.0226 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | -0.0179 |
| ID | GSE30365 |
| Title | Transcript Profiling of Arcuate Nucleus in Response to Electroacupuncture on Rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM753495 | 2Hz_HR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | 0.0 |
| GSM753496 | 2Hz_HR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | 0.3364 |
| GSM753497 | 2Hz_HR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | 0.0 |
| GSM753498 | 2Hz_NR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | 0.0 |
| GSM753499 | 2Hz_NR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.3785 |
| GSM753500 | 2Hz_NR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.1375 |
| GSM753501 | 100Hz_HR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | 0.0 |
| GSM753502 | 100Hz_HR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | -0.4854 |
| GSM753503 | 100Hz_HR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | -1.7225 |
| GSM753504 | 100Hz_NR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | -1.5361 |
| GSM753505 | 100Hz_NR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | 0.5799 |
| GSM753506 | 100Hz_NR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | 0.0 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 3.2 | |
| GSM5121 | Isoflurane single exposure control-2 | 7.9 | |
| GSM5122 | Isoflurane single exposure control-3 | 8.4 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 19.2 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 5.8 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 3.9 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 2.6 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 5.5 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.550360901 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.352694991 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.155143779 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.282948298 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.403431377 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.168915894 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.49844388 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.414315124 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.47831064 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.295005072 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.37724335 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.327319234 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.62161115 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.474553692 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.365878871 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.255350557 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.717005454 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.614610471 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.576516893 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.406098199 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.505007778 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.18258528 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.345624851 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.406195964 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.891178 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.841692 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.85117 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.886638 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.813333 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.749351 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.760148 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.792236 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.665407 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.917706 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.711076 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.792285 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.861272 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.807425 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.80217 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.936176 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.795601 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.710812 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 6.054011 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.884169 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.914589 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.652182 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.797499 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 5.674275 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 195.7718 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 133.0131 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 9.478729125 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 33.79396847 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 48.15733254 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 12.12764537 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 37.53082607 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 20.30201191 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 54.65885698 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 42.58418398 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 26.96807453 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 37.14088134 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 22.56807017 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 2.097377797 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 39.72510094 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 66.04080038 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.550360901 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.352694991 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.155143779 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.282948298 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.403431377 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.168915894 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.49844388 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.414315124 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.47831064 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.295005072 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.37724335 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 3.327319234 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.62161115 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.474553692 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.365878871 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.255350557 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.717005454 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.614610471 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.576516893 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.406098199 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.505007778 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 3.18258528 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.345624851 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 3.406195964 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 9.478729125 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 33.79396847 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 48.15733254 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 12.12764537 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 37.53082607 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 20.30201191 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 54.65885698 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 42.58418398 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 26.96807453 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 37.14088134 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 22.56807017 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 2.097377797 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 39.72510094 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 66.04080038 |
| ID | GSE58803 |
| Title | Transcript Profiling of Periaqueductal Gray in Response to Electroacupuncture on Rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1419812 | 2Hz_HR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.149638782 |
| GSM1419813 | 2Hz_HR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.029292523 |
| GSM1419814 | 2Hz_HR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419815 | 2Hz_HR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419816 | 2Hz_HR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419817 | 2Hz_NR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419818 | 2Hz_NR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.145794987 |
| GSM1419819 | 2Hz_NR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419820 | 2Hz_NR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.614881263 |
| GSM1419821 | 100Hz_HR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 1.289493609 |
| GSM1419822 | 100Hz_HR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.116765322 |
| GSM1419823 | 100Hz_HR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419824 | 100Hz_HR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419825 | 100Hz_HR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419826 | 100Hz_NR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419827 | 100Hz_NR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419828 | 100Hz_NR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.2303751 |
| GSM1419829 | 100Hz_NR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.612033696 |
| GSM1419830 | 100Hz_NR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419831 | 2Hz_HR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.094019748 |
| GSM1419832 | 2Hz_HR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.325506736 |
| GSM1419833 | 2Hz_HR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.145332429 |
| GSM1419834 | 2Hz_HR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.535945615 |
| GSM1419835 | 2Hz_HR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.43764976 |
| GSM1419836 | 2Hz_NR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.120026518 |
| GSM1419837 | 2Hz_NR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 1.27550397 |
| GSM1419838 | 2Hz_NR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.988489273 |
| GSM1419839 | 2Hz_NR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.017879644 |
| GSM1419840 | 2Hz_NR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.189926145 |
| GSM1419841 | 100Hz_HR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.503084446 |
| GSM1419842 | 100Hz_HR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -1.140796338 |
| GSM1419843 | 100Hz_HR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.196802276 |
| GSM1419844 | 100Hz_HR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.324698096 |
| GSM1419845 | 100Hz_HR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -1.990887072 |
| GSM1419846 | 100Hz_NR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.298659838 |
| GSM1419847 | 100Hz_NR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.541969489 |
| GSM1419848 | 100Hz_NR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.186274943 |
| GSM1419849 | 100Hz_NR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419850 | 100Hz_NR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.814199195 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 14.0 | |
| GSM5084 | Control 2 | 5.7 | |
| GSM5085 | Control 3 | 8.9 | |
| GSM5086 | Control 4 | 28.7 | |
| GSM5087 | Control 5 | 8.0 | |
| GSM5090 | Control 6 | 12.1 | |
| GSM5105 | Control 7 | 16.4 | |
| GSM5106 | Control 8 | 3.3 | |
| GSM5107 | Control 9 | 6.7 | |
| GSM5108 | Halothane 10 exposure-1 | 18.1 | |
| GSM5109 | Halothane 10 exposures-2 | 28.0 | |
| GSM5110 | Halothane 10 exposures-3 | 14.7 | |
| GSM5111 | Halothane 5 exposures-1 | 12.4 | |
| GSM5112 | Halothane 5 exposures-2 | 15.5 | |
| GSM5113 | Halothane 5 exposures-3 | 4.1 | |
| GSM5114 | Isoflurane 10 exposures-1 | 18.1 | |
| GSM5115 | Isoflurane 10 exposures-2 | 13.5 | |
| GSM5116 | Isoflurane 10 exposures-3 | 10.8 | |
| GSM5117 | Isoflurane 5 exposures-1 | 17.5 | |
| GSM5118 | Isoflurane 5 exposures-2 | 20.2 | |
| GSM5119 | Isoflurane 5 exposures-3 | 14.1 | |
| GSM11379 | Control 10 | 13.2 | |
| GSM11380 | Control 11 | 2.6 | |
| GSM11381 | Control 12 | 9.4 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 8.83052 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 2.70576 |
